The European Medicines Agency (EMA) recently announced that it has selected six drugs to move forward in its adaptive pathways (formerly adaptive licensing) pilot program. In March 2014 EMA announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results